Asimov, Inc. is an intelligent design and synthetic biology company headquartered in Boston, Massachusetts, offering tools and platforms for engineered biology.
Subscribe to see Asimov’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Asimov is a biotech company headquartered in United States. It has raised at least $179.7M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $175M in January 2023. Xcout tracks 12 named people at Asimov, including Ben Gordon (Chief Innovation Officer). Xcout recorded 13 job postings from Asimov in the last 90 days.
6 more named people on record for Asimov, with roles, board committees and tenure — see the full roster →
At least $179.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $175M | 8 named | |
| Seed | $4.7M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 13 job postings from Asimov in the last 90 days, from a hiring record Xcout has kept since May 2026.
The weekly hiring trend, the roles and locations behind it — see Asimov's hiring signals →
A few of Asimov's closest competitors — see the full list of competitors and alternatives →
Ginkgo Bioworks is a biotechnology research company headquartered in Boston, Massachusetts, that provides autonomous lab platforms for automated biological experiments.
Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum. The enterprise caters to a broad spectrum of industries, encompassing specialized chemical manufacturing, the agricultural sector, food production, consumer goods, and pharmaceuticals. Furthermore, Ginkgo Bioworks has forged a partnership with Selecta Biosciences, Inc., for the joint advancement of the ImmTOR technology platform. The company, founded in 2008, is headquartered in Boston, Massachusetts.
Aether Bio is a biotechnology company headquartered in Menlo Park, California, that develops AI-designed molecular machines. Utilizing its Protein Function Model, the company accelerates protein discovery for advanced manufacturing, super materials, and critical mineral processing.
Arcadia Science is an evolutionary biology company founded and led by scientists, based in Emeryville, California. It operates in biotechnology research, with roles like Scientist, Platform Development and Evolutionary Cell Biologist.
Adaptyv Biosystems operates an automated cloud laboratory that provides protein testing and validation services for protein designers and AI-first engineering teams. The company allows users to submit protein sequences digitally and delivers experimental data such as binding affinity, expression, and thermostability measurements.
Andon Bio builds a measurement platform for protein production that monitors cellular supply chains during protein synthesis. The company connects sequence demand to expression yields, helping researchers predict manufacturability and streamline protein design.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.